Benefits of omalizumab on anxiety and depression in patients with severe asthma

BACKGROUND: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Invent...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzer, Fatih, Ozbudak, Omer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121347/
https://www.ncbi.nlm.nih.gov/pubmed/30197766
http://dx.doi.org/10.22088/cjim.9.3.228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121347/
https://www.ncbi.nlm.nih.gov/pubmed/30197766
http://dx.doi.org/10.22088/cjim.9.3.228

Ejemplares similares